Research groups
Colleges
Gabriel Davis Jones
BSc (Hons), MD
Lead Researcher
Biography
Dr Gabriel Davis Jones is a medically-trained computer scientist and software developer in the Nuffield Department of Clinical Neurosciences and a lead researcher for the Oxford Martin Programme on Global Epilepsy. He specialises in developing technologies that apply artificial intelligence methodologies to novel biomedical and clinical big data problems in order to better understand health and disease in local-to-global scalable systems.
His most recent work has been in developing smart-device based machine learning models for the prediction of epileptic seizures as the lead computer scientist for the Epilepsy Pathway Innovation in Africa (EPInA) program and is also responsible for the software development of a suite of smart-device based cognitive testing tasks to enable remote neuropsychological testing of patients with neurological disorders using automated scoring metrics.
Contact information
Websites
-
Oxford Martin Programme on Global Epilepsy
Lead Researcher
Recent publications
-
Placental capillary pericytes release excess extracellular vesicles under hypoxic conditions inducing a pro-angiogenic profile in term pregnancy.
Journal article
Kandzija N. et al, (2023), Biochem Biophys Res Commun, 651, 20 - 29
-
Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control study
Journal article
Jones GD. et al, (2023), The Lancet Digital Health, 5, e185 - e193
-
Computerized Analysis of Antepartum Cardiotocography: A Review
Journal article
Jones GD. et al, (2022), MATERNAL-FETAL MEDICINE, 4, 130 - 140
-
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
Journal article
Sen A. et al, (2021), Trials, 22
-
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-Blind, Placebo Controlled, Randomised Cross Over Proof of Concept Study
Journal article
Sen A. et al, (2021)